A 4 week intake of drug to find a natural substance that may modify energy balance and may enhance health in combination with lifestyle changes with possible decrease in body weight.
This study is a double-blind, placebo-controlled, single center, randomized, parallel arm clinical trial to test the impact of Dihydrocapsiate (placebo, 3 and 9 mg/d) ingested for 4 weeks on resting metabolic rate and fat oxidation measured by indirect calorimetry.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Enrollment
79
Capsules will contain dihydrocapsiate 3 mg/d or 9 mg/d or placebo
Capsules will contain dihydrocapsiate 3 mg/d or 9 mg/d or placebo
Capsules will contain dihydrocapsiate 3 mg/d or 9 mg/d or placebo
Pennington Biomedical Research Center
Baton Rouge, Louisiana, United States
The consumption of dihydrocapsiate will significantly increase resting energy expenditure and fat oxidation
Time frame: 4 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.